Michael Ross Ascuitto

Michael Ross Ascuitto

Auto-generated profile, based on publicly available information

Michael Ross Ascuitto

Department of Family Medicine, Baton Rouge General Hospital, Baton Rouge, LA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Peptides
Verified
Journal Article
Closed access
RBRoberto de la Salud Bea
Roberto de la Salud Bea
MAMichael Ross Ascuitto
Michael Ross Ascuitto
LJLaura Elena Luque de Johnson
Laura Elena Luque de Johnson

28 June 2017 in Antibiotics
Verified
Journal Article
Open access
PDF file
RBRoberto de la Salud Bea
Roberto de la Salud Bea
APAdam F. Petraglia
Adam F. Petraglia
MAMichael R. Ascuitto
Michael R. Ascuitto
QBQuentin M. Buck
Quentin M. Buck
Seven analogs of the natural, α-helix peptides IsCT1 and IsCT2—found in the venom of scorpion Opithancatus Madagascariensis—have been synthesized and tested to compare their antibacterial and hemolytic activity against natural peptides. In general, results show that increasing hydrophobicity by substituting positions 5 and 9 of the sequences with alanine, valine, and leucine, enhances antibacterial activity. However, this also increases hemolytic activity. The analog with an increased net positive charge from +1 to +3 produces moderate bacterial growth inhibition but also has high hemolytic activity. On the other hand, the analog with a negative net charge (−1) has low antibacterial properties but also no cytotoxicity under the tested conditions, a similar result was found for five of the seven studied analogs.

23 August 2021 in Family Practice
Verified
Journal Article
Closed access
MAMichael Ascuitto
Michael Ascuitto
DGDalia Guertin
Dalia Guertin
KWKaycee Weaver
Kaycee Weaver
Background: Acute unilateral vision loss is an ophthalmological emergency. It can have multiple aetiologies, and physicians must be able to quickly determine the cause of the condition, as immediate intervention may prevent permanent vision loss. Acute unilateral vision loss has not previously been associated with a patent foramen ovale (PFO). Objective: We describe a patient who presented with painless sudden loss of vision in his left eye. He was diagnosed to have central retinal artery occlusion, likely from a paradoxical embolus associated with an atrial septal aneurysm containing a PFO. The patient underwent successful percutaneous closure of the PFO without complication. This report details the evaluation and differential diagnosis of acute unilateral vision loss. Additionally, the controversy of whether a PFO should be closed prophylactically for stroke prevention is discussed. Conclusion: Acute unilateral vision loss from central retinal artery occlusion may be caused by a paradoxical embolus originating from an atrial septal aneurysm with a PFO. This case should be considered in the controversy of whether prophylactic closure of a PFO could be beneficial for primary prevention of stroke.